PRI-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRI-002, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) [Phase 2]